The University of Cambridge has been awarded £2 million from the UK Medical Research Council and the Government of India’s Department for Biotechnology to develop a partnership with the National Institute for Research in Tuberculosis (NIRT) in Chennai.
A new transformative point-of-care diagnostic which gives instant results for the detection of genetic material from the HIV virus is being rolled out across Africa. The small, highly portable machine - known as SAMBA II - will help transform the lives of millions, especially HIV exposed infants who have a one in two chance of early death if HIV infection is not diagnosed within the first six weeks of life and if they are not immediately initiated on treatment.
Scientists have discovered that the presence of a specific protein can distinguish between prostate cancers that are aggressive and need further treatment, and those that may never seriously harm the patient.
The most common cause of artificial joint failure is loosening of the prosthetic implant. Dr Athina Markaki is designing materials to anchor them securely.